UNRELATED DONOR REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

Myeloablative allogeneic hematopoietic cell transplantation (HCT) may cure patients with relapsed or refractory Hodgkin Lymphoma (HL), but is associated with a high treatment-related mortality (TRM). Reduced intensity and nonmyeloablative (RIC/NST) conditioning regimens aim to lower TRM. We analyzed...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Devetten, Marcel P., Hari, Parameswaran N., Carreras, Jeanette, Logan, Brent R., van Besien, Koen, Bredeson, Christopher N., Freytes, César O., Peter Gale, Robert, Gibson, John, Giralt, Sergio A., Goldstein, Steven C., Gupta, Vikas, Marks, David I., Maziarz, Richard T., Vose, Julie M., Lazarus, Hillard M., Anderlini, Paolo
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2929570/
https://ncbi.nlm.nih.gov/pubmed/19135949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.11.011
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares